文献速递产科母胎医学

妊娠与肺动脉高压:病例系列及文献综述

Pregnancy and pulmonary arterial hypertension: a case series and literature review.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-03-27

该单中心病例系列回顾2005至2019年7例妊娠合并肺动脉高压患者的资料,其中5例孕前诊断、2例孕晚期诊断,均使用前列环素类药物,多数接受联合靶向治疗。母亲死亡率为29%,超过70%行择期剖宫产,2例产后需ECMO且均死亡,无新生儿死亡。结论认为妊娠合并肺动脉高压仍难以耐受,多学科团队管理至关重要。

要点

  • 妊娠合并肺动脉高压母亲死亡率高达29%,2例需ECMO者均死亡。
  • 超过70%行择期剖宫产,多数采用硬膜外麻醉,1例经阴道分娩成功。
  • 尽管靶向治疗进步,妊娠合并肺动脉高压仍难以耐受,需多学科团队管理。

核心结论

  • 病例系列及现有文献显示,尽管肺动脉高压靶向治疗和产后护理显著进步,妊娠合并肺动脉高压仍难以耐受。
  • 多学科团队管理仍是此类患者管理的核心。

研究设计与样本

  • 单中心回顾性病例系列,纳入2005至2019年在该院分娩的肺动脉高压患者,共7例。
  • 5例为孕前诊断肺动脉高压,2例为孕晚期诊断。

主要发现

  • 所有患者均开始使用前列环素类药物,多数接受肺动脉高压靶向联合治疗。
  • 母亲死亡率为29%。
  • 超过70%的病例行择期剖宫产,1例需紧急剖宫产,1例经阴道分娩成功。
  • 多数患者采用硬膜外麻醉。
  • 2例产后需体外膜肺氧合(ECMO),且均死亡;无新生儿死亡。

临床怎么用

  • 妊娠合并肺动脉高压患者应由多学科团队管理。
  • 分娩方式以择期剖宫产为主,麻醉多采用硬膜外。
  • 产后需警惕病情恶化,必要时考虑ECMO支持。

局限性

  • 单中心回顾性病例系列,样本量仅7例。
  • 数据来自电子健康记录,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the development of advanced therapies for pulmonary arterial hypertension, pregnancy remains contraindicated in these patients owing to high maternal and fetal morbidity and mortality. Limited data exist regarding pregnancy management and outcome in this unique patient population. We describe a series of pregnant patients diagnosed as having pulmonary arterial hypertension before or during pregnancy who delivered at a tertiary center with a comprehensive and established pulmonary vascular disease program. OBJECTIVE: This study aimed to describe a single institution's experience and review the existing literature for pregnancy management and outcomes in patients with pulmonary arterial hypertension. STUDY DESIGN: A review of all patients with pulmonary arterial hypertension who were admitted for delivery between 2005 and 2019 at our institution was performed. All data were extracted from the electronic health record and included patient demographics, pulmonary arterial hypertension subtype, pulmonary arterial hypertension-targeted therapies, and mode of delivery and anesthesia. RESULTS: A total of 7 patients were identified; 5 patients had a prepartum diagnosis of pulmonary arterial hypertension, whereas 2 patients were diagnosed as having pulmonary arterial hypertension during the third trimester. All patients were started on prostacyclins and the majority were on combination pulmonary arterial hypertension-targeted therapy. The maternal mortality rate was 29%. Elective cesarean delivery was performed in more than 70% of cases, whereas 1 patient required an urgent cesarean delivery and 1 patient had a successful vaginal delivery. Most patients had epidural anesthesia. Notably, 2 patients required extracorporeal membrane oxygenation after delivery and both died. There were no cases of neonatal mortality. CONCLUSION: Our cases series and the published literature to date show that pregnancy in pulmonary arterial hypertension remains poorly tolerated despite marked advancements in pulmonary arterial hypertension-targeted therapies and postpartum care. A multidisciplinary team approach remains essential for the management of these patients.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Yang JZ, Fernandes TM, Kim NH, et al. Pregnancy and pulmonary arterial hypertension: a case series and literature review. Am J Obstet Gynecol MFM. 2021. PMID: 33785463. doi:10.1016/j.ajogmf.2021.100358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。